Is AFYA a buy? — what our data shows
Afya is Brazil's largest medical education company — it runs medical schools and digital health tools that help train the next generation of doctors across Brazil.
Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.
The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.
The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.
What our data shows
Our data on Afya is focused on one main thing: who owns it. About 63 big investment funds have reported holding shares — and the names on that list are serious: Berkshire Hathaway, Tiger Global, and Coatue Management are all in. Those are some of the most respected long-term investors in the world, which is a meaningful signal. The one thing that gives us pause is that this stock doesn't trade a lot of hands each day — it's relatively thinly traded, which can make it harder to buy or sell quickly without moving the price.
The takeaway
The heavyweight fund backing is genuinely interesting, but the low trading activity is worth keeping an eye on — if you ever needed to move quickly, that could be a real constraint.
Thinking about AFYA?
Our data likes 10 other stocks even more right now — under-the-radar names we believe have monster upside potential. Get the free list before the crowd catches on.
Show me the 10 stocks — free →Have your own question?
Ask in plain English — our data answers. Free for retail readers.
Ask a question →Informational research, not personalized investment advice.